FI895795A0 - Menetelmä optisesti aktiivisten 2-oksoimidatsolidiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä optisesti aktiivisten 2-oksoimidatsolidiinijohdannaisten valmistamiseksi

Info

Publication number
FI895795A0
FI895795A0 FI895795A FI895795A FI895795A0 FI 895795 A0 FI895795 A0 FI 895795A0 FI 895795 A FI895795 A FI 895795A FI 895795 A FI895795 A FI 895795A FI 895795 A0 FI895795 A0 FI 895795A0
Authority
FI
Finland
Prior art keywords
optically active
oxoimidazolidine
preparation
group
chem
Prior art date
Application number
FI895795A
Other languages
English (en)
Swedish (sv)
Other versions
FI97133B (fi
FI97133C (fi
Inventor
Kimiaki Hayashi
Hitoshi Kubota
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of FI895795A0 publication Critical patent/FI895795A0/fi
Publication of FI97133B publication Critical patent/FI97133B/fi
Application granted granted Critical
Publication of FI97133C publication Critical patent/FI97133C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI895795A 1988-12-16 1989-12-04 Menetelmä optisesti aktiivisten 2-oksoimidatsolidiinijohdannaisten valmistamiseksi FI97133C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31874588 1988-12-16
JP63318745A JPH0645603B2 (ja) 1988-12-16 1988-12-16 光学活性2‐オキソイミダゾリジン誘導体の製法

Publications (3)

Publication Number Publication Date
FI895795A0 true FI895795A0 (fi) 1989-12-04
FI97133B FI97133B (fi) 1996-07-15
FI97133C FI97133C (fi) 1996-10-25

Family

ID=18102470

Family Applications (1)

Application Number Title Priority Date Filing Date
FI895795A FI97133C (fi) 1988-12-16 1989-12-04 Menetelmä optisesti aktiivisten 2-oksoimidatsolidiinijohdannaisten valmistamiseksi

Country Status (17)

Country Link
US (1) US5013845A (fi)
EP (1) EP0373881B1 (fi)
JP (1) JPH0645603B2 (fi)
KR (1) KR950009364B1 (fi)
CN (1) CN1032308C (fi)
AT (1) ATE100817T1 (fi)
AU (1) AU622959B2 (fi)
CA (1) CA2004606C (fi)
DE (1) DE68912745T2 (fi)
DK (1) DK174701B1 (fi)
ES (1) ES2062044T3 (fi)
FI (1) FI97133C (fi)
HK (1) HK34195A (fi)
HU (1) HU203730B (fi)
IE (1) IE64315B1 (fi)
IL (1) IL92456A0 (fi)
SG (1) SG4795G (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104513292A (zh) * 2013-09-29 2015-04-15 山东新时代药业有限公司 一种雷米普利的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5788165A (en) * 1980-11-21 1982-06-01 Tanabe Seiyaku Co Ltd 2-oxoimidazolidine-4-carboxylic acid derivative and its preparation
JPS6058233B2 (ja) * 1982-05-24 1985-12-19 田辺製薬株式会社 2−オキソイミダゾリジン誘導体及びその製法
JPS6058233A (ja) * 1983-08-11 1985-04-04 ザ・アプジヨン・カンパニー 滅菌懸濁液及び溶液の保持及び混合装置

Also Published As

Publication number Publication date
EP0373881A3 (en) 1990-08-16
JPH0645603B2 (ja) 1994-06-15
AU4619589A (en) 1990-06-21
IE894004L (en) 1990-06-16
CN1043705A (zh) 1990-07-11
ES2062044T3 (es) 1994-12-16
IL92456A0 (en) 1990-08-31
CN1032308C (zh) 1996-07-17
DK638289D0 (da) 1989-12-15
DE68912745T2 (de) 1994-05-11
CA2004606C (en) 1997-01-07
ATE100817T1 (de) 1994-02-15
SG4795G (en) 1995-06-16
EP0373881A2 (en) 1990-06-20
JPH02164869A (ja) 1990-06-25
DK174701B1 (da) 2003-09-29
HUT52064A (en) 1990-06-28
AU622959B2 (en) 1992-04-30
US5013845A (en) 1991-05-07
EP0373881B1 (en) 1994-01-26
KR950009364B1 (ko) 1995-08-21
DK638289A (da) 1990-06-17
CA2004606A1 (en) 1990-06-16
IE64315B1 (en) 1995-07-26
DE68912745D1 (de) 1994-03-10
KR900009603A (ko) 1990-07-05
FI97133B (fi) 1996-07-15
HU203730B (en) 1991-09-30
FI97133C (fi) 1996-10-25
HU896640D0 (en) 1990-02-28
HK34195A (en) 1995-03-17

Similar Documents

Publication Publication Date Title
FI95245B (fi) Menetelmä rytmihäiriöiden vastaisten pyrimidiinidionijohdannaisten valmistamiseksi
EP0256503A3 (en) Pyridinecarboxamide derivatives and their use as fungicide
DE3851279D1 (de) Organische Salze von Physostigminderivaten.
ATE26212T1 (de) Verwendung von amino-phenylessigs ure-derivaten zur herstellung eines immunomodulatoren arzneimittels.
AU4466789A (en) Xanthine derivatives
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
DE3864707D1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
NO174848C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte
EP0331078A3 (en) Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
FI893682A (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
ATE82292T1 (de) Verfahren zur herstellung von 2-alpha-methyl-2beta-(1,2,3-triazol-1-yl)methylpenam-3-alphacarbons|urederivaten.
FI895795A0 (fi) Menetelmä optisesti aktiivisten 2-oksoimidatsolidiinijohdannaisten valmistamiseksi
EP0555479A4 (fi)
HUT62855A (en) Process for producing glycerol derivatives and pharmaceutical compositions comprising same
EP0432841A3 (en) Spiro-indoline-oxazine compounds with photochromatic and photosensitizing characteristics and the process for their preparation
FI893369A0 (fi) Foerfarande foer syntetisering av optiskt aktiva aminosyror.
DK424888D0 (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
FR2629456B1 (fr) Derives des acides 7-(1-imidazolyl),1,4-dihydro-4-oxo-6,8-difluoro-1-cyclopropyl-3-quinoleincarboxylique, leur preparation et leur application en tant que medicaments
ES488385A0 (es) Procedimiento de preparacion de derivados de la xantona

Legal Events

Date Code Title Description
FG Patent granted

Owner name: TANABE SEIYAKU CO., LTD

BB Publication of examined application
FG Patent granted

Owner name: TANABE SEIYAKU CO., . LTD.